888-969-2592
Kalkine 0
countryflagCA

Cronos Group Inc

Healthcare CA CRON

2.77CAD
0.01(0.36%)

Last update at 2025-07-04T16:33:00Z

Day Range

2.742.77
LowHigh

52 Week Range

2.273.50
LowHigh

Fundamentals

  • Previous Close 2.76
  • Market Cap1002.09M
  • Volume10104
  • P/E Ratio13.68
  • Dividend Yield-%
  • EBITDA-34.55950M
  • Revenue TTM124.59M
  • Revenue Per Share TTM0.33
  • Gross Profit TTM 39.73M
  • Diluted EPS TTM0.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -134.55900M -397.13500M -73.27300M 1165.57M -13.74125M
Minority interest 0.00000M 1.10M -3.19600M -0.85300M 0.10M
Net income -168.73400M -396.70400M -74.62000M 3741.33M -14.10028M
Selling general administrative 86.29M 106.63M 95.89M 60.99M 15.90M
Selling and marketing expenses 22.28M 44.94M 34.39M 23.05M 3.02M
Gross profit 11.97M -17.53400M -25.83300M -17.86400M 8.27M
Reconciled depreciation 13.12M 15.40M 7.04M 3.91M 1.84M
Ebit -116.01200M 6.79M -179.34700M -121.48400M -13.29486M
Ebitda -59.18500M 22.19M -160.08500M -1405.33900M -11.61428M
Depreciation and amortization 56.83M 15.40M 19.26M -1283.85500M 1.68M
Non operating income net other - - - - -
Operating income -116.01200M 6.79M -179.34700M -121.48400M -13.29486M
Other operating expenses 207.92M 271.35M 226.07M 139.91M 24.82M
Interest expense 22.54M 0.03M 0.19M 1.24M 0.08M
Tax provision 34.17M -0.43100M 1.35M 0.00000M 0.36M
Interest income 52.16M 162.73M 18.60M 1271.53M 0.48M
Net interest income 22.54M 9.07M 18.38M -4.22600M 0.08M
Extraordinary items 0.00000M -0.50000M -0.65000M -0.36300M -
Non recurring - - - - -
Other items - - - - -
Income tax expense 34.17M -0.43100M 1.35M -2575.75800M 0.36M
Total revenue 91.90M 74.44M 46.72M 23.75M 11.53M
Total operating expenses 127.98M 179.38M 153.51M 98.29M 21.57M
Cost of revenue 79.94M 91.97M 72.55M 41.61M 3.26M
Total other income expense net -18.54700M -403.92000M 106.07M 1287.06M -0.44639M
Discontinued operations - -0.50000M -0.65000M -0.36300M -0.89400M
Net income from continuing ops -168.73400M -396.70400M -74.62000M 1165.57M -14.10028M
Net income applicable to common shares -168.73400M -396.10700M -73.13700M 1166.51M -21.63600M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 1166.31M 1140.09M 1213.01M 1397.74M 1925.68M
Intangible assets 11.13M 21.08M 26.70M 18.08M 69.72M
Earning assets - - - - -
Other current assets 6.28M 5.41M 7.11M 8.97M 12.34M
Total liab 55.33M 43.96M 72.05M 63.46M 217.51M
Total stockholder equity 1064.06M 1099.57M 1143.88M 1337.24M 1711.36M
Deferred long term liab - - - - -
Other current liab 0.04M 0.10M 55.62M 40.44M 163.41M
Common stock - 613.73M 611.32M 595.50M 569.26M
Capital stock 669.88M 613.73M 611.32M 595.50M 569.26M
Retained earnings 457.71M 416.72M 490.68M 659.42M 1064.51M
Other liab - - 1.38M 1.99M 2.19M
Good will 63.45M 1.06M 1.03M 1.10M 179.52M
Other assets - - 0.19M 80.73M 87.66M
Cash 858.80M 669.29M 764.64M 886.97M 1078.02M
Cash and equivalents - - 764.64M 886.97M 1078.02M
Total current liabilities 49.70M 41.40M 68.12M 54.37M 206.83M
Current deferred revenue - 28.17M - - -
Net debt - -666.73800M -760.76800M -877.16700M -1068.20900M
Short term debt - 0.99M 1.33M 2.71M 1.32M
Short long term debt - - - - -
Short long term debt total - 2.55M 3.88M 9.81M 9.81M
Other stockholder equity - 48.45M 42.68M 32.47M 34.60M
Property plant equipment - - 62.83M 82.95M 197.38M
Total current assets 936.11M 933.31M 960.16M 1079.72M 1372.17M
Long term investments 2.81M 54.74M 89.75M 135.16M 19.23M
Net tangible assets - - 1116.15M 1318.07M 1462.12M
Short term investments 0.00000M 192.24M 113.08M 117.68M 211.77M
Net receivables 15.46M 35.88M 37.77M 33.29M 26.04M
Long term debt - - - - -
Inventory 33.15M 30.50M 37.56M 32.80M 44.00M
Accounts payable 16.97M 12.13M 11.16M 11.22M 42.10M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 20.68M -0.79700M 49.87M 43.00M
Additional paid in capital - - - - -
Common stock total equity - - - - 569.26M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.04M 72.54M 80.73M 87.66M
Deferred long term asset charges - - - - -
Non current assets total 230.07M 206.78M 252.85M 318.02M 553.51M
Capital lease obligations 2.02M 2.55M 3.88M 9.81M 9.81M
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.84200M -19.40600M 20.15M -603.53900M -89.18673M
Change to liabilities -0.86300M -2.37300M 4.17M 13.48M 12.71M
Total cashflows from investing activities -1.84200M -28.89800M 20.15M -603.27200M -93.90800M
Net borrowings - - -2.41400M -16.48400M 11.58M
Total cash from financing activities -2.89700M -13.44200M -5.46500M 1856.94M 113.54M
Change to operating activities -2.75800M 1.97M -5.30000M -15.09400M -2.38200M
Net income -168.73400M -397.20400M -75.27000M 1165.57M -14.10028M
Change in cash -122.32900M -191.05000M -121.67000M 1175.77M 17.20M
Begin period cash flow 886.97M 1078.02M 1199.69M 23.93M 6.76M
End period cash flow 764.64M 886.97M 1078.02M 1199.69M 23.96M
Total cash from operating activities -88.94800M -153.61600M -142.45700M -130.00700M -7.15036M
Issuance of capital stock - - 0.00000M 0.00000M 107.22M
Depreciation 13.12M 15.40M 7.04M 3.91M 1.84M
Other cashflows from investing activities 3.19M -16.63600M 55.54M 0.41M -0.23100M
Dividends paid - - - - 0.00000M
Change to inventory -7.21700M 11.56M -28.09400M -51.88800M -3.89198M
Change to account receivables -2.71100M -13.16300M -4.72400M -0.70200M -2.21948M
Sale purchase of stock - 0.02M 0.12M 1878.06M 118.12M
Other cashflows from financing activities -2.89700M -13.44200M -3.05100M 1922.14M 6.32M
Change to netincome 46.00M 229.09M -42.42200M -1246.48500M 8.61M
Capital expenditures 5.03M 12.26M 35.39M 38.95M 84.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 20.66M -2.00500M -33.94300M -54.20800M 3.48M
Stock based compensation 15.12M 10.15M 15.36M 11.62M 3.11M
Other non cash items 30.89M 220.04M -56.99700M -1256.90500M -1.84651M
Free cash flow -93.98000M -165.87800M -177.84800M -168.96000M -91.41208M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRON
Cronos Group Inc		 0.01 0.36% 2.77 13.68 - 8.04 0.67 0.02 -1.9458
BHC
Bausch Health Companies Inc		 -0.02 0.21% 9.42 - 1.69 0.32 18.74 2.33 8.07
CURA
Curaleaf Holdings Inc.		 0.01 0.89% 1.14 - 138.89 0.62 0.72 1.00 5.90
GUD
Knight Therapeutics Inc.		 0.01 0.25% 6.04 60.30 80.65 1.61 0.76 1.27 6.84
TLRY
Tilray Inc		 -0.01 1.45% 0.68 - 1000.00 0.66 0.14 0.56 -2.299

Reports Covered

Stock Research & News

View All

Profile

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

Cronos Group Inc

4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0

Key Executives

Name Title Year Born
Mr. Michael Ryan Gorenstein J.D. Pres, CEO & Chairman 1987
Ms. Shannon Buggy Sr. VP & Global Head of People 1970
Ms. Anna Shlimak Sr. VP of Corp. Affairs & Strategy 1986
Mr. James Holm Chief Financial Officer NA
Mr. Carlos Cortez VP, Controller & Principal Accounting Officer 1973
Mr. Shayne J. Laidlaw Director of Investor Relations & Strategy NA
Mr. Terry Gregory-Joseph Doucet Sr. VP of Legal & Regulatory Affairs and Corp. Sec. 1990
Mr. Jeffrey David Jacobson Chief Growth Officer 1986
Mr. Arye Weigensberg Head of R&D NA
Mr. Kevin B Gifford VP of Fin. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.